PMID- 1599509 OWN - NLM STAT- MEDLINE DCOM- 19920708 LR - 20231213 IS - 0006-2952 (Print) IS - 0006-2952 (Linking) VI - 43 IP - 10 DP - 1992 May 28 TI - Inhibition of mast cell secretion by oxidation products of natural polyamines. PG - 2237-45 AB - Mast cells secrete many biologically active compounds upon stimulation by immunoglobulin E (IgE) and specific antigen (Ag), anaphylatoxins, as well as a number of cationic compounds which include drugs, kinins and neuropeptides. The effects of the two naturally occurring polyamines, spermine (SP) and spermidine (SPD), on mast cell secretion were studied because they have been implicated in the modulation of cellular processes, possibly through their cationic charge or the regulation of calcium ions. SP and SPD over the range of 10(-7) to 10(-4) M inhibited the release of 5-hydroxytryptamine (5-HT, serotonin) triggered by compound 48/80 (C48/80) in a time- and concentration-dependent manner, as long as at least 2% calf serum (CS) was present. SP also inhibited secretion of both histamine and serotonin stimulated immunologically by using IgE and anti-rat IgE. This inhibition was not accompanied by cytotoxicity. The major available polyamine metabolites tested, N1-acetyl spermine (N1-acSP) and N8-acetyl spermidine (N8-acSPD), also showed inhibition in the presence of CS, whereas putrescine, N8,N1-hexamethylene-bis-acetamide (HMBA) and benzylamine did not. Fetal bovine serum (FBS), as well as human and rat serum, which do not contain polyamine oxidase, did not result in any inhibition with the polyamines tested. Inhibitors of the polyamine oxidase blocked the polyamine effect, indicating that the inhibition of mast cell secretion must derive from aldehydes produced from these polyamines. Addition of the aldehyde inhibitor phenylhydrazine (phi-HDZ), simultaneously with, but not following the polyamines, blocked their inhibitory effect, further strengthening the involvement of aldehydes. These results indicate that naturally occurring polyamines may regulate mast cell secretion through metabolic products of polyamine oxidase, a similar enzyme of which is also present in human liver, placenta and pregnant serum. FAU - Vliagoftis, H AU - Vliagoftis H AD - Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA 02111. FAU - Boucher, W S AU - Boucher WS FAU - Mak, L L AU - Mak LL FAU - Theoharides, T C AU - Theoharides TC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Biochem Pharmacol JT - Biochemical pharmacology JID - 0101032 RN - 2FZ7Y3VOQX (Spermine) RN - 333DO1RDJY (Serotonin) RN - 4091-50-3 (p-Methoxy-N-methylphenethylamine) RN - EC 1.5.- (Oxidoreductases Acting on CH-NH Group Donors) RN - U87FK77H25 (Spermidine) SB - IM MH - Animals MH - Cattle MH - Dose-Response Relationship, Drug MH - Humans MH - Male MH - Mast Cells/*drug effects/metabolism MH - Oxidation-Reduction MH - Oxidoreductases Acting on CH-NH Group Donors/metabolism MH - Rats MH - Rats, Inbred Strains MH - Serotonin/metabolism MH - Spermidine/metabolism/*pharmacology MH - Spermine/metabolism/*pharmacology MH - p-Methoxy-N-methylphenethylamine/*pharmacology MH - Polyamine Oxidase EDAT- 1992/05/28 00:00 MHDA- 1992/05/28 00:01 CRDT- 1992/05/28 00:00 PHST- 1992/05/28 00:00 [pubmed] PHST- 1992/05/28 00:01 [medline] PHST- 1992/05/28 00:00 [entrez] AID - 0006-2952(92)90183-J [pii] AID - 10.1016/0006-2952(92)90183-j [doi] PST - ppublish SO - Biochem Pharmacol. 1992 May 28;43(10):2237-45. doi: 10.1016/0006-2952(92)90183-j.